1. Home
  2. DERM vs SNCR Comparison

DERM vs SNCR Comparison

Compare DERM & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • SNCR
  • Stock Information
  • Founded
  • DERM 2014
  • SNCR 2000
  • Country
  • DERM United States
  • SNCR United States
  • Employees
  • DERM N/A
  • SNCR N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • SNCR EDP Services
  • Sector
  • DERM Health Care
  • SNCR Technology
  • Exchange
  • DERM Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • DERM 181.0M
  • SNCR 87.5M
  • IPO Year
  • DERM 2021
  • SNCR 2006
  • Fundamental
  • Price
  • DERM $7.15
  • SNCR $7.65
  • Analyst Decision
  • DERM Strong Buy
  • SNCR Strong Buy
  • Analyst Count
  • DERM 1
  • SNCR 1
  • Target Price
  • DERM $9.00
  • SNCR $13.00
  • AVG Volume (30 Days)
  • DERM 179.1K
  • SNCR 142.2K
  • Earning Date
  • DERM 08-11-2025
  • SNCR 08-05-2025
  • Dividend Yield
  • DERM N/A
  • SNCR N/A
  • EPS Growth
  • DERM N/A
  • SNCR N/A
  • EPS
  • DERM N/A
  • SNCR N/A
  • Revenue
  • DERM $56,243,000.00
  • SNCR $172,842,000.00
  • Revenue This Year
  • DERM $28.99
  • SNCR $2.07
  • Revenue Next Year
  • DERM $52.61
  • SNCR $5.42
  • P/E Ratio
  • DERM N/A
  • SNCR N/A
  • Revenue Growth
  • DERM N/A
  • SNCR 4.64
  • 52 Week Low
  • DERM $3.54
  • SNCR $6.00
  • 52 Week High
  • DERM $8.25
  • SNCR $15.46
  • Technical
  • Relative Strength Index (RSI)
  • DERM 53.22
  • SNCR 55.94
  • Support Level
  • DERM $6.78
  • SNCR $7.10
  • Resistance Level
  • DERM $7.34
  • SNCR $7.97
  • Average True Range (ATR)
  • DERM 0.35
  • SNCR 0.42
  • MACD
  • DERM 0.03
  • SNCR 0.17
  • Stochastic Oscillator
  • DERM 78.81
  • SNCR 75.63

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: